Obesity in children

Pediatric Endocrinology: Obesity, Diabetes Mellitus, Insulin Resistance, and Hypoglycemia

Volumn , Issue , 2006, Pages 1-36

  Alemzadeh, Ramin ^a   Rising, Russell ^b   Lifshitz, Fima ^c,d,e  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b EMTAC Inc   (United States)

^c SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057666670     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (443)

1. Controlling the Global Obesity Epidemic. World Health Organization Obesity and Overweight Fact Sheet, 2003 (http://www.who.int/nut/obs.htm).
2. Hodge AM, Dowse GK, Zimmet PZ, Collins VR. Prevalence and secular trends in obesity in Pacific and Indian Ocean island populations. Obes Res 1995; 2: 77S-87S.
3. Fernald LC, Gutierrez JP, Neufeld LM, et al. High prevalence of obesity among the poor in Mexico. JAMA 2004; 291:2544-2545.
4. Mendez MA, Monteiro CA, Popkin BM. Overweight exceeds underweight among women in most developing countries. Am J Clin Nutr 2005; 81:714-721.
5. FlegalKM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288:1723-1727.
6. American Obesity Association. AOAFact Sheets Obesity in the US, 2004, http://www.obesity.org/subs/fastfacts/obesity_youth.shtml.
7. Goel MS, McCarty EP, Phillips RS, Wee CC. Obesity among US immigrant subgroups by duration of residence. JAMA 2004; 292:2860-2867.
8. Troiano RP, Flegal KM. Overweight children and adolescents: description, epidemiology, and demographics. Pediatrics 1998; 101:497-504.
9. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002; 288:1728-1732.
10. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004; 291:2847-2850.
11. Strauss RS, Pollack HA. Epidemic increase in childhood overweight, 1986-1998. JAMA 2001; 286:2845-2848.
12. Kramer MS, Morin I, Yang H, et al. Why are babies getting bigger? Temporal trends in fetal growth and its determinants. J Pediatr 2002; 141:538-542.
13. Stettler N, Zemel BS, Kumanyika S, Stallings VA. Infant weight gain and childhood overweight status in a multicenter, cohort study. Pediatrics 2002; 109:194-199.
14. Ong KK, Ahmed ML, Emmett PM, Preece MA, Dunger DB. Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. BMJ 2000; 320: 967-971.
15. Gasser T, Ziegler P, Seifert P, Molinari L, Largo RH, Prader A. Prediction of adult skinfolds and body mass from infancy through adolescence. Ann Hum Biol 1995; 22:217-233.
16. Merritt RJ. Obesity. Curr Probl Pediatr 1982; 12:1-58.
17. Stark O, Atkins E, Wolff OH, Douglas JW. Longitudinal study of obesity in the National Survey of Health and Development. Br Med J 1981; 283:13-17.
18. Sun SS, Wu W, Chumlea WC, Roche AF. Predicting overweight and obesity in adulthood from body mass index values in childhood and adolescence. Am J Clin Nutr 2002; 76:653-658.
19. Freedman DS, Khan LK, Serdula MK, Dietz WH, Srinivasan SR, Berenson GS. The relation of childhood BMI to adult adiposity: the Bogalusa Heart Study. Pediatrics 2005; 115:22-27.
20. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA 2004; 291:1238-1245.
21. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005; 293:1861-1867.
22. Olshansk SJ, Passaro DJ, Hershow RC, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 2005; 352:1138-1145.
23. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Correction: actual causes of death in the United States, 2000. JAMA 2005; 293:293-294.
24. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005; 294:1255-1259.
25. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003; 138:24-32.
26. Fontaine KR, ReddenDT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2003; 289:187-193.
27. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to N Engl J Med 1992; 327:1350-1355.
28. Freedman DS, Khan LK, Dietz WH, Srinivasan SR, Berenson GS. Relationship of childhood obesity to coronary heart disease risk factors in adulthood: the Bogalusa Heart Study. Pediatrics 2001; 108:712-718.
29. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-1607.
30. Williams DP, Going SB, Lohman TG, et al. Body fatness and risk for elevated blood pressure, total cholesterol, and serum lipoprotein ratios in children and adolescents. Am J Public Health 1992; 82:358-363.
31. Webber LS, Srinivasan SR, Wattigney WA, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to adulthood: the Bogalusa heart study. Am J Epidemiol 1991; 133:884-899.
32. Webber LS, Cresanta JL, Voors AW, Berenson GS. Tracking of cardiovascular disease risk factor variables in school-age children. J Chron Dis 1983; 36:647-660.
33. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 1989; 9(suppl 1):I19-I32.
34. Berenson GS, Wattigney WA, Tracy RE, Newman WP 3rd, Srinivasan Dalferes ER Jr., Strong JP. Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study). Am J Cardiol 1992; 70:851-858.
35. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350:2362-2374.
36. Williams B. Insulin resistance and syndrome X. Lancet 1994; 344:521-524.
37. McLaughlin TL. Insulin resistance syndrome and obesity. Endocr Pract 2003; 9:58-62.
38. Landsberg L. Hypertension and insulin resistance syndrome. Endocr Pract 2003; 9:63-66.
39. Chen W, Srinivasan SR, Elkasababny A, Berenson GS. Cardiovascular risk factor clustering features of insulin resistance syndrome (syndrome X) in a biracial (blackwhite) population of children, adolescents, and young adults. Am J Epidemiol 1999; 150:666-674.
40. Arsalanian S, Suprasongsin C. Insulin sensitivity, lipids, and body composition in childhood: is '‘syndrome X’' present? J Clin Endocrinol Metab 1996; 81:1058-1062.
41. Steinberger J, Moorehead C, Katch V, Rochini AP. Relationship between insulin resistance and abnormal lipid profile in obese adolescents. J Pediatr 1995; 126: 690-695.
42. Viner RM, Segal TY, Lichtarowicz-Krynska E, Hindmarsh P. Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child 2005; 90:10-14.
43. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287:356-359.
44. William CL, Hayman LL, Daniels SR, et al. Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2002; 106:143-160.
45. Cruz ML, Goram MI. The metabolic syndrome in children and adolescents. Curr Diab Rep 2004; 4:53-62.
46. Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002; 346:802-810.
47. Flier JS. Metabolic importance of acanthosis nigricans. Arch Dermatol 1985; 121:193-194.
48. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005; 352:1223-1236.
49. Ciampelii M, Fulghesu AM, Cucinelli F, et al. Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome. Metabolism 1999; 48:167-172.
50. Nestler JE. Insulin resistance syndrome and polycystic ovary syndrome. Endocr Pract 2003; 9:86-89.
51. De Leo V, la Marca A, Petraglia F. Insulin-lowering agents in the management of polycystic ovary syndrome. Endocr Rev 2003; 24:633-667.
52. Janssen I. Combined influence of body mass index and waist circumference on coronary artery disease risk factors among children and adolescents. Pediatrics 2005; 115:1623-1630.
53. Zhu S, Wang Z, Heshka S, Heo M, Faith MS, Heymsfiled SB. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr 2002; 76:743-749.
54. Chen W, Srinivasan SR, Li S, Xu J, Berenson GS. Metabolic syndrome variables at low levels in childhood are beneficially associated with adulthood cardiovascular risk: the Bogalusa Heart Study. Diabetes Care 2005; 28:126-131.
55. Valle M, Martos R, Gascon F, Canete R, Zafra MA, Morales R. Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab 2005; 31:55-62.
56. Balady GJ. Survival of the fittest-more evidence. N Engl J Med 2002; 346:852-854.
57. Chakravarthy MV, Booth FW. Inactivity and inaction: we can’t afford either. Arch Pediatr Adolesc Med 2003; 157:731-732.
58. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004; 350:664-671.
59. Shulman AI, Mangelsdorf DJ. Retinoid’ receptor heterodimers in the metabolic syndrome. N Engl J Med 2005; 353:604-615.
60. Davidson MB. Is treatment of insulin resistance beneficial independent of glycemia? Diabetes Care 2003; 26: 3184-3186.
61. Caro JF, Dohm LG, Pories WJ, Sinha MK. Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes. Diabetes Metab Rev 1989; 5:665-689.
62. Schade DS, Eaton RP. Dose response to insulin in man: differential effects on glucose and ketone body regulation. J Clin Endocrinol Metab 1977; 44:1038-1053.
63. Le Stunff C, Bougneres PF. Time course of increased lipid and decreased glucose oxidation during early phase of childhood obesity. Diabetes 1993; 42:1010-1016.
64. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbance of diabetes mellitus. Lancet 1963; 1:758-789.
65. Glass AR. Endocrine aspects of obesity. Med Clin North Am 1989; 73:139-160.
66. Rosenbaum M, Leibel RL. Pathophysiology of childhood obesity. Adv Pediatr 1988; 35:73-137.
67. Pontiroli AE. Type 2 diabetes mellitus is becoming the most common type of diabetes in school children. Acta Diabetol 2004; 41:85-90.
68. Glaser NS. Non-insulin-dependent diabetes mellitus in childhood and adolescence. Pediatr Clin North Am 1997; 44:307-337.
69. Dean HE, Mundy RLL, Moffatt M. Non-insulin-dependent diabetes mellitus in Indian children in Mannitoba. Can Med Assoc J 1992; 147:52-57.
70. Dean H. NIDDM-Y in First Nation children in Canada. Clin Pediatr 1998; 37:89-96.
71. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulindependent diabetes among adolescents. J Pediatr 1996; 128:608-615.
72. Kitagawa T, Owada M, Urakami T, Tajima N. Epidemiology of type 1 (insulin-dependent) and type 2 (noninsulin-dependent) diabetes mellitus in Japanese children. Diabetes Res Clin Pract 1994; 24(suppl):S7-S13.
73. Kitagawa T, Owada M, Urakami T, Yamauchi K. Increased incidence of non-insulin-dependent diabetes mellitus among Japanese school children correlates with an increased intake of animal protein and fat. Clin Pediatr 1998; 37:111-115.
74. Betts P, Mulligan J, Ward P, Smith B, Wilkin T. Increasing body weight predicts the earlier onset of insulin dependent diabetes in childhood. The accelerator hypothesis. Diabet Med 2005; 22:144-151.
75. Adelman RD, Restaino IG, Alon US, Blowey DL. Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J Pediatr 2001; 138:481-485.
76. Kambham N, Markowitz GS, Valeri AM, Lin J, L’Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59:1498-1509.
77. Nanda K. Non-alcoholic steatohepatitis in children. Pediatr Transplant 2004; 8:613-618.
78. Matteoni CA, Younossi, Gramlich T, Boparai N, Liu YC, McCallough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116:1413-1419.
79. Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120:1183-1192.
80. Bennion LJ, Knowler WC, Mott DM, Spagnola AM, Bennett PH. Development of lithogenic bile during puberty in Pima Indians. N Engl J Med 1979; 300: 873-876.
81. Liddle RA, Goldstein RB, Saxton J. Gallstone formation during weight-reduction dieting. Arch Intern Med 1989; 149:1750-1753.
82. Dietz WH Jr. Obesity in infants, children and adolescents in the United States. I. Identification, natural history and aftereffects. Nutr Res 1981; 1:117-137.
83. Tracey VV, De NC, Harper JR. Obesity in respiratory infection in infants and young children. Br Med J 1971; 1:16-18.
84. Mallory GB Jr., Fiser DH, Jackson R. Sleep-associated breathing disorders in morbidly obese children and adolescents. J Pediatr 1989; 115:892-897.
85. Strollo PJ Jr., Rogers RM. Obstructive sleep apnea. N Engl J Med 1996; 271:99-104.
86. Shelton KE, Gay SB, Hollowell DE, Woodson H, Suratt PM. Mandible enclosure of upper airway and weight in obstructive sleep apnea. Am Rev Respir Dis 1993; 148: 195-200.
87. Horner RL, Mohiaddin RH, Lowell DG, et al. Sites and sizes of fat deposits around the pharynx in obese patients with obstructive sleep apnea and weight matched controls. Eur Respir J 1989; 2:613-622.
88. Shepard JW Jr. Cardiopulmonary consequences of obstructive sleep apnea. Mayo Clin Proc 1990; 65:1250-1259.
89. Ford ES. The epidemiology of obesity and asthma. J Allergy Clin Immunol 2005; 115:897-909.
90. Hancox RJ, Milne BJ, Poulton R, et al. Sex differences in the relation between body mass index and asthma and atopy in a birth cohort. Am J Respir Crit Care Med 2005; 171:440-445.
91. Bibi H, Shoseyov D, Feigenbaum D, et al. The relationship between asthma and obesity in children: is it real or a case of over diagnosis? J Asthma 2004; 41:403-410.
92. Spivak H, Hewitt MF, Onn A, Half EE. Weight loss and improvement of obesity-related illness in 500 U.S. patients following laparoscopic adjustable gastric banding procedure. Am J Surg 2005; 189:27-32.
93. Kelsey JL, Acheson RM, Keggi KJ. The body build of patients with slipped capital femoral epiphysis. Am J Dis Child 1972; 124:276-281.
94. Kling TF Jr. Angular deformities of the lower limbs in insulin-dependent diabetes mellitus among adolescents. J Pediatr Children Orthop Clin NorthAm1987; 18:513-527.
95. Timm NL, Grupp-Phelan J, Ho ML. Chronic ankle morbidity in obese children following an acute ankle injury. Arch Pediatr Adolesc Med 2005; 159:33-36.
96. Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M. Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 2004; 114:104-108.
97. Neaye RL. Maternal body weight and pregnancy outcome. Am J Clin Nutr 1990; 52:273-279.
98. Shaw GM, Velie EM, Schaffer D. Risk of neural tube defect-affected pregnancies among obese women. JAMA 1996; 275:1093-1096.
99. Werler MM, Louik C, Shapiro S, Mitchell AA. Prepregnant weight in relation to risk of neural tube defects. JAMA 1996; 275:1089-1092.
100. Wadden TA, Stunkard AJ. Psychopathology and obesity. Ann N Y Acad Sci 1987; 499:55-56.
101. Gortmaker SL, Must A, Perrin JM, Sobol AM, Dietz WH. Social and economic consequences of overweight in adolescence and young adulthood. N Engl J Med 1993; 329: 1008-1012.
102. Staffieri JR. A study of social stereotype of body image in children. J Pers Soc Psychol 1967; 7:101-104.
103. Stunkard A, Burt V. Obesity and the body image. II. Age at onset of disturbances in body image. Am J Psychiatry 1967; 123:1443-1447.
104. Davison KK, Birch LL. Weight status, parent reaction, and self-concept in five-year-old girls. Pediatrics 2001; 107:46-53.
105. Birch LL, Fisher JO. Mothers’ child-feeding practices influence daughters’ eating and weight. Am J Clin Nutr 2000; 71:1054-1061.
106. Vander Wall JS, Thelen MH. Eating and body image concerns among obese and average weight children. Addit Behav 2000; 25:775-778.
107. Monello LF, Mayer F.Obese adolescent girls: a unrecognized '‘minority’' group? Am J Clin Nutr 1963; 13:35-39.
108. Canning H, Mayer J. Obesity: its possible effect on college acceptance. N Engl J Med 1996; 275:1172-1174.
109. Schwimmer JB, Burwinkle TM, Varni JW. Health-related quality of life of severely obese children and adolescents. JAMA 2003; 289:1813-1819.
110. Williams J, Wake M, Hesketh K, Maher E, Waters E. Health-related quality of life of overweight and obese children. JAMA 2005; 293:70-76.
111. Cugini P, Cilli M, Salandri A, et al. Anxiety, depression, hunger and body composition: III. Their relationships in obese patients. Eat Weight Disord 1999; 4:115-120.
112. Decaluwe V, Braet C. Prevalence of binge-eating disorder in obese children and adolescents seeking weight-loss treatment. Int J Obes Relat Metab Disord 2003; 27:404-409.
113. Telch CF, Pratt EM, Niego SH. Obese women with binge eating disorder define the term binge. Int J Eat Disord 1998; 7:115-117.
114. deZwaan M. Binge eating disorder and obesity. Int J Obes Relat Metab Disord 2001; 25(suppl 1):S51-S55.
115. Ackard DM, Neumark-Sztainer D, Story M, Perry C. Overeating among adolescents: prevalence and associations with weight-related characteristics and psychological health. Pediatrics 2003; 111:67-74.
116. Mustillo S, Worthman C, Erkanli A, Keeler G, Angold A, Costello EJ. Obesity and psychiatric disorder: developmental trajectories. Pediatrics 2003; 111:851-859.
117. Carpenter KM, Hasin DS, Allison DB, Faith MS. Relationships between obesity and DSM-IV major depressive disorder, suicide ideation, and suicide attempts: results from a general population study. Am J Public Health 2000; 90:251-257.
118. Allison DB, Fontaine KR, Heo M, et al. The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry 1999; 60; 215-220.
119. Allison DB, Casey DE. Antipsychotic-induced weight gain: a review of the literature. J Clin Psychiatry 2001; 62(suppl 7): 22-31.
120. Schaeffer JL, Ross RG J. Childhood-onset schizophrenia: premorbid and prodromal diagnostic and treatment histories. Am Acad Child Adolesc Psychiatry 2002; 41: 538-545.
121. Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353:1209-1223.
122. Pine DS, Goldstein RB, Wolk S, Weissman MM. The association between childhood depression and adulthood body mass index. Pediatrics 2001; 107:1049-1056.
123. Goodman E, Whitaker RC. A prospective study of the role of depression in the development and persistence of adolescent obesity. Pediatrics 2002; 110:497-504.
124. Schwartz TL, Nihalani L, Virk S, Jindal S, Chilton M. Psychiatric medication-induced obesity: treatment options. Obes Rev 2004; 5:233-238.
125. Kreipe RE. Eating disorders in adolescents and older children. Pediatr Rev 1999; 12:410-421.
126. Pugliese MT, Lifshitz F, Grad G, Fort P, Marks-Katz M. Fear of obesity: a cause of short stature and delayed puberty. N Engl J Med 1983; 309:513-518.
127. Moses N, Banilvy M, Lifshitz F. Fear of obesity among adolescent girls. Pediatrics 1989; 83:393-398.
128. Richardson SA, Goodman N, Hastorf H, et al. Cultural uniformity in reaction to physical disabilities. Am Sociol Rev 1961; 26:241-247.
129. Neumark-Sztainer D, Hannan P.Weight-related behaviors among adolescent girls and boys: results from a national survey. Arch Pediatr Adolesc Med 2000; 154:569-577.
130. Lifshitz F. Fear of obesity in childhood. Ann N Y Acad Sci 1993; 699:230-236.
131. Lifshitz F, Tarim O, Smith MM. Nutrition in adolescence. Review. Endocrinol Metab Clin North Am 1993; 22: 673-683.
132. Pugliese M, Lifshitz F, Fort P, Recker B, Ginsberg L. Pituitary-hypothalamic response in adolescents with growth failure due to fear of obesity. J Am Coll Nutr 1987; 6:113-120.
133. Lifshitz F, Moses N, Cervantes C, Ginsberg L. Nutritional dwarfing in adolescents. Semin Adolesc Med 1987; 3: 255-266.
134. Neumark-Sztainer D, Rock CL, Thornquist MD, Cheskin LJ, Neuhouser ML, Barnett MJ. Weight-control behaviors among adults and adolescents: associations with dietary intake. Prev Med 2000; 5:381-391.
135. Abramovitz B, Birch L. Five-year-old girls’ ideas about dieting are predicted by their mothers’ dieting. J Am Diet Assoc 2000; 100:1157-1163.
136. Schur E, Sanders M, Steiner H. Body dissatisfaction and dieting in young children. Int J Eat Disord 2000; 27:74-82.
137. Stice E, AgrasW, Hammer L. Risk factors for the emergence of childhood eating disturbances: a five-year prospective study. Int J Eat Disord 1999; 25:375-387.
138. Maynard LM, Galuska DA, Blanck HM, Serdula MK. Maternal perceptions of weight status of children. Pediatrics 2003; 111:1226-1231.
139. Johnson S, Birch L. Parents’ and children’s adiposity and eating style. Pediatrics 1994; 94:653-661.
140. Hood MY, Moore LL, Sundarajan-Ramamurti A, Singer M, Cupples LA, Ellison RC. Parental eating attitudes and the development of obesity in children. The Framingham Children’s Study. Int J Obes 2000; 24:1319-1325.
141. Field AE, Austin SB, Taylor CB, et al. Relation between dieting and weight change among preadolescents and adolescents. Pediatrics 2003; 112:900-906.
142. http://www.healthaffairs.org.
143. Finkelstein EA, Fiebelkorn IC, Wang G. State-level estimates of annual medical expenditures attributable to obesity. Obes Res 2004; 12:18-24.
144. Birmingham CL, Muller JL, Palepu A, Spinelli JJ, Anis AH. The cost of obesity in Canada. Can Med Assoc J 1999; 160:483-488.
145. Wang G, Dietz WH. Economic burden of obesity in youths aged 6 to 17 years: 1979-1999. Pediatrics 2002; 109(5):e81-e91.
146. Pronk NP, Boucher J. Systems approach to childhood and adolescent obesity prevention and treatment in a managed care organization. Int J Obes Rel Metab Disord 1999; 2:S38-S42.
147. Harp JB, Hecht L. Obesity in the national football league. JAMA 2005; 293:1061-1062.
148. Miller LA, Grunwald GK, Johnson SL, Krebs NF. Disease severity at time of referral for pediatric failure to thrive and obesity: time for a paradigm shift? J Pediatr 2002; 141:121-124.
149. Quattrin T, Liu E, Shaw N, Shine B, Chiang E. Obese children who are referred to the pediatric endocrinologist: characteristics and outcome. Pediatrics 2005; 115:348-351.
150. Batterham RL, Cohen MA, Ellis SM, et al. Inhibition of food intake in obese subjects by peptide YY3-36 N Engl J Med 2003; 349:941-948.
151. Pugliese MT, Recker B, Lifshitz F. A Survey to determine the prevalence of abnormal growth patterns in a suburban school district. J Adolesc Health Care 1988; 9: 181-182.
152. Hammer LD, Kraemer HC, Wilson DM, Ritter PL, Dornbusch SM. Standardized percentile curves of body-mass index for children and adolescents. Am J Dis Child 1991; 145:259-263.
153. http://www.cdc.gov/nchs/data/ad/ad314.pdf.
154. National Center for Health Statistics, U.S. Department of Health, Education andWelfare. NCHS Growth Curves for Children: Birth to 18 years. Series H, No. 165, DHEW Publication No. (PHS) 78-1650, 1977.
155. Yajnik CS, Yudkin JS. The Y-Y paradox. Lancet 2004; 363:163.
156. Franklin MF. Comparison of weight and height relations in boys from 4 countries. Am J Clin Nutr 1999; 70:157S-162S.
157. Bellizzi MC, Dietz WH. Workshop on childhood obesity: summary of the discussion. Am J Clin Nutr 1999; 70: 173S-175S.
158. Malina RM, Katzmarzyk PT. Validity of the body mass index as indicator of the risk and presence of overweight in adolescents. Am J Clin Nutr 1999; 70:131S-136S.
159. Dietz WH, Bellizzi MC. Introduction: the use of body mass index to assess obesity in children. Am J Clin Nutr 1999; 70:123S-125S.
160. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974; 32:77-97.
161. Must A, Dallal GE, Dietz WH. Reference data for obesity: 85th and 95th percentiles of body mass index (wt/ht2) and triceps skinfold thickness. Am J Clin Nutr 1991; 53:839-846.
162. http://www.cdc.gov/nchs/about/major/nhanes/testcomp.
163. Megan AM, Gomez TG, Bernauer EM, Mole PM. Evaluation of a new air displacement plethysmograph for measuring human body composition. Med Sci Sport Exerc 1995; 27:1686-1691.
164. de Ridder CM, de Boer RW, Seidell JC, et al. Body fat distribution in pubertal girls quantified by magnetic resonance imaging. Int J Obes Relat Metab Disord 1992; 16:443-449.
165. LocknerDW, Heyward VH, Baumgartner RN, Jenkins KA. Comparison of air-displacement plethysmography, hydrodensitometry, and dual X-ray absorptiometry for assessing body composition of children 10 to 18 years of age. Ann N Y Acad Sci 2000; 904:72-78.
166. Ma G, Yao M, Liu Y, et al. Validation of a new pediatric air-displacement plethysmograph for assessing body composition in infants. Am J Clin Nutr 2004; 79:653-660.
167. Guo SM, Roche AF, Houtkooper L. Fat-free mass in children and young adults predicted from bioelectric impedance and anthropometric variables. Am J Clin Nutr 1989; 50:435-443.
168. Houtkooper LB, Going BS, Lohman TG, Roche AF, Van Loan M. Bioelectrical impedance estimation of fat-free mass in children and youth: a cross-validation study. J Appl Physiol 1992; 72:366-373.
169. Wells JC, Fuller NJ, Dewit O, Fewtrell MS, Elia M, Cole TJ. Four-component model of body composition in children: density and hydration of fat-free mass and comparison with simpler models. Am J Clin Nutr 1999; 69:904-912.
170. Czinner A, Varady M. Quantitative determination of fatty tissue on body surface in obese children by ultrasound method. Pediatr Pathol 1992; 27:7-10.
171. Armellini F, Zamboni M, Rigo L, et al. Sonography detection of small intra-abdominal fat variations. Int J Obes 1991; 15:847-852.
172. Ellis KJ. Measuring body fatness in children and young adults: comparison of bioelectric impedance analysis, total body electrical conductivity, and dual-energy X-ray absorptiometry. Int J Obes Relat Metab Disord 1996; 20:866-873.
173. Kohrt WM. Preliminary evidence that DEXA provides an accurate assessment of body composition. J Appl Physiol 1998; 84:372-377.
174. Paradisi G, Smith L, Burtner C, et al. Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care 1999; 22:1310-1317.
175. Kvist H, Chowdhury B, Grangard U, Tylen U, Sjostrom L. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am J Clin Nutr 1988; 48:1351-1361.
176. Ross R, Shaw KD, Martel Y, de Guise J, Avruch L. Adipose tissue distribution measured by magnetic resonance imaging in obese women. Am J Clin Nutr 1993; 57:470-475.
177. Fiorotto ML, Cochran WJ, Klish WJ. Fat-free mass and total body water of infants estimated from total body electrical conductivity measurements. Pediatr Res 1987; 22:417-421.
178. www.forum.lowcarber.org/archive/index.php/t-48103. html.
179. www.nutricraze.com/health_talk/Fat-Track-Pro-Digital-Body-Fat-Measurement-System-to-424.html.
180. www.equistat.co.uk/research.htm.
181. www.scales-r-us.com/scales.php/Scales/146.
182. www.medicalscales.com/seca/adult/700.html.
183. www.nutrition-software-review.toptenreviews.com/dietmaster-2000-software.html.
184. Kissebah AH, Vydelingum N, Murray R, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982; 54:254-260.
185. Evans DJ, Hoffmann RG, Kalkhoff RK, Kissebah AH. Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism 1984; 33:48-75.
186. Kalkhoff RK, Hartz AH, Rupley D, Kissebah AH, Kelber W. Relationship of body fat distribution to blood pressure, carbohydrate tolerance, and plasma lipids in healthy obese women. J Lab Clin Med 1983; 102:621-627.
187. Peiris AN, Hennes MI, Evans DJ, Wilson CR, Lee MB, Kissebah AH. Relationship of anthropometric measurements of body fat distribution to metabolic profile in premenopausal women. Acta Med Scand Suppl 1988; 723:179-188.
188. Peiris AN, Struve MF, Mueller RA, Lee MB, Kissebah AH. Glucose metabolism in obesity: influence of body fat distribution. J Clin Endocrinol Metab 1988; 67:760-767.
189. Hirschler C, Aranda V, Calcagno MdeL, Maccalini G, Jadzinsky M. Can waist circumference identify children with the metabolic syndrome? Arch Pediatr Adolesc Med 2005; 159:740-744.
190. Zamboni M, Armellini F, Milani MP, et al. Evaluation of regional body fat distribution: comparison between W/H ratio and computed tomography in obese women. J Intern Med 1992; 232:341-347.
191. Garn SM, Sullivan TV, Hawthorne VM. Fatness and obesity of the parents of obese individuals. Am J Clin Nutr 1989; 50:1308-1313.
192. Reeder BA, Senthilselvan A, Despres J, et al. The association of cardiovascular disease risk factors with abdominal obesity in Canada. Canadian Heart Health Surveys Research Group. CMAJ 1997; 157(suppl 17): S39-S45.
193. Okosun IS, Choi S, Dent MM, Jobin T, Dever GE. Abdominal obesity defined as a larger than expected waist girth is associated with racial/ethnic differences in risk of hypertension. J Hum Hypertens 2001; 15:307-312.
194. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 2005; 81:555-563.
195. Fernandez JR, Redden DT, Pietrobelli A, Allison DB. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 2004; 145:439-444.
196. Gray GA. Contemporary Diagnosis and Management of Obesity. Newtown, PA: Handbooks in Health Care, 1998:120.
197. Ong KK, Dunger DB. Birth weight, infant growth and insulin resistance. Eur J Endocrinol 2004; 151(suppl 3): U131-U139.
198. Roberts SB, Savage J, Coward WA, Chew B, Lucas A. Energy expenditure and intake in infants born to lean and overweight mothers. N Engl J Med 1988; 318:461-466.
199. Ravussin E, Burnand B, Schutz Y, Jequier E. Twenty-fourhour energy expenditure and resting metabolic rate in obese, moderately obese, and control subjects. Am J Clin Nutr 1982; 35:566-573.
200. Dewey KG, Heinig MJ, Nommsen LA, Peerson JM, Lonnerdal B. Breast-fed infants are leaner than formulafed infants at 1y of age: the DARLING study. Am J Clin Nutr 1993; 57:140-145.
201. Wells JC, Stanley M, Laidlaw AS, Day JM, Davies PS. Energy intake in early infancy and childhood fatness. Int J Obes Relat Metab Disord 1998; 22:387-392.
202. Davis PS, Wells JC, Fieldhouse CA, Day JM, Lucas A. Parental body composition and infant energy expenditure. Am J Clin Nutr 1995; 61:1026-1029.
203. Cole CR, Rising R, Hakim A, et al. Comprehensive assessment of the components of energy expenditure in 97 infants using a new infant respiratory chamber. J Am Coll Nutr 1999; 18:233-241.
204. Rising R, Duro D, Cedillo M, et al. Daily metabolic rate in healthy infants. J Pediatr 2003; 143:180-185.
205. Rising R, Lifshitz F. Relationship between maternal obesity and infant feeding-interactions. Nutr J 2005; 4:17.
206. Hill JO, Peters JC. Environmental contributions to the obesity epidemic. Science 1998; 280:1371-1374.
207. Kramer MS, Barr RG, Leduc DG, Boisjoly C, McVey-White L, Pless IB. Determinants of weight and adiposity in the first year of life. J Pediatr 1985; 106:10-14.
208. Cutting TM, Fisher JO, Grimm-Thomas K, Birch LL. Like mother, like daughter: familial patterns of overweight are mediated by mothers’ dietary disinhibition. Am J Clin Nutr 1999; 69:608-613.
209. DrabmamRS, Cordua GD, Hammer D, Jarvie GJ, Horton S. Developmental trends in eating rates of normal and overweight preschool children. Child Dev 1979; 50:211-216.
210. Agras WS, Kraemer HC, Berkowitz RI, Korner AF, Hammer LD. Does a vigorous feeding style influence early development of adiposity? J Pediatr 1987; 110: 799-804.
211. Udal JN, Harrison GG, Vaucher Y, Walson PD, Morrow G III. Interaction of maternal and neonatal obesity. Pediatrics 1978; 62:17-21.
212. Vohr BR, McGarvey ST. Growth patterns of largefor-gestational-age and appropriate-for-gestational-age infants of gestational diabetic mothers and control mothers at age 1 year. Diabetes Care 1997; 20:1066-1072.
213. Vohr BR, McGarvey ST, Tucker R. Effects of maternal gestational diabetes on offspring adiposity at 4-7 years of age. Diabetes Care 1999; 22:1284-1291.
214. Stunkard AJ, Srensen TI, Hanis C, et al. An adoption study of human obesity. N Engl J Med 1986; 314:193-198.
215. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE. The body-mass index of twins who have been reared apart. N Engl J Med 1990; 322:1483-1487.
216. Bray GA. The inheritance of corpulence. In: Cioffi LA, James WPT, Van Itallie TB, eds. The BodyWeight Regulatory System: Normal and Disturbed Mechanisms. New York: Raven Press, 1981:61-64.
217. Heitmann BL, Harris JR, Lissner L, Pedersen NL. Genetic effects on weight change and food intake in Swedish adult twins. Am J Clin Nutr 1999; 69:597-602.
218. Faith MS, Pietrobelli A, Nunez C, Heo M, Heymsfield SB, Allison DB. Evidence for independent genetic influences on fat mass and body mass index in a pediatric twin sample. Pediatrics 1999; 104:61-67.
219. Valencia ME, Bennett PH, Ravussin E, Esparza J, Fox C, Schultz LO. The Pima Indians in Sonora, Mexico. Nutr Rev 1999; 57:S55-S57.
220. Esparza J, Fox C, Harper IT, Bennett PH, Schultz LO, Valencia ME, Ravussin E. Daily energy expenditure in Mexican and USA Pima Indians: low physical activity as a possible cause of obesity. Int J Obes Relat Metab Disord 2000; 24:55-59.
221. Ravussin E, Bogardus C. Energy expenditure in the obese: is there a thrifty gene? Infusionstherapie 1990; 17:108-112.
222. Chakavarthy MV, Booth FW. Eating, exercise, and '‘thrifty’' genotypes: connecting the dots toward an evolutionary understanding of modern chronic diseases. J Appl Physiol 2004; 96:3-10.
223. Barsh GS, Farooqi IS, O’Rahilly S. Genetics of bodyweight regulation. Nature 2000; 404:644-651.
224. Walder K, Hanson RL, Kobes S, Knowler WC, Ravussin E. An autosomal genomic scan for loci linked to plasma leptin concentration in Pima Indians. Int J Obes Relat Metab Disord 2000; 24:559-565.
225. Duggirala R, Blangero J, Almasy L, et al. A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican Americans. Am J Hum Genet 2001; 68:1149-1164.
226. Zhu X, Cooper RS, Luke A, et al. A genome-wide scan for obesity in African-Americans. Diabetes 2002; 51: 541-544.
227. Perusse L, Rice T, Chagnon YC, et al. A genome-wide scan for abdominal fat assessed by computed tomography in the Quebec Family Study. Diabetes 2001; 50:614-621.
228. Comuzzie AG. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet 1997; 15:273-276.
229. Lee JH, Reed DR, Li WD, et al. Genome scan for human obesity and linkage to markers in 20q13. Am J Hum Genet 1999; 64:196-209.
230. Feitosa MF, Borecki IB, Rich SS, et al. Quantitative-trait loci influencing body-mass index reside on chromosomes 7 and 13: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet 2002; 70:72-82.
231. Saar K, Geller F, Ruschendorf F, et al. Genome scan for childhood and adolescent obesity in German families. Pediatrics 2003; 111:321-327.
232. Petry CJ, Ong KK, Barratt BJ, et al. ALSPCA Study Team. Common polymorphism in H19 associated with birthweight and cord blood IGF-II levels in humans. BMC Genet 2005; 6:22.
233. Bazaes RA, PetryCJ, OngKK, et al. Insulin gene VNTR genotype is associated with insulin sensitivity and secretion in infancy. Clin Endocrinol (Oxf) 2003; 59: 599-603.
234. Bray GA, Dahms WT, Swerdloff RS, et al. The Prader-Willi syndrome: a study of 40 patients and a review of the literature. Medicine (Baltimore) 1983; 62:59-80.
235. DelParigi A, Teschop M, Heiman ML, et al. High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader-Willi syndrome. J Clin Endocrinol Metab 2002; 87:5461-5464.
236. Bekx MD, Carrel AA, Shriver TC, Li Z, Allen DB. Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi syndrome. J Pediatr 2003; 143:372-376.
237. Schoeller DA, Levitksy LL, Bandini LG, Dietz WW, Walczak A. Energy expenditure and body composition in Prader-Willi syndrome. Metabolism 1988; 37:115-120.
238. Ledbetter DH, Riccardi VM, Airhart SD, Strobel RJ, Keenan BS, Crawford JD. Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. N Engl J Med 1981; 304:325-329.
239. Bauman ML, Hogan GR. Laurence-Moon-Biedl syndrome. Report of two unrelated children less than 3 years of age. Am J Dis Child 1973; 126:119-126.
240. Spiegel AM. Pseudohypoparathyroidism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. New York: McGraw-Hill, 1989: 2013-2027.
241. Ong KK, Amin R, Dunger DB. Pseudohypoparathyroidism- another monogenic obesity syndrome. Clin Endocrinol 2000; 52:389-391.
242. Farooqi IS, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999; 341:879-884.
243. Ozata M, Ozdemir IC, Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 1999; 84:3686-3695.
244. Farooqi IS, Keogh JM, Kamath S, et al. Partial leptin deficiency and human adiposity. Nature 2001; 414:34-35.
245. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372:425-432.
246. Diamond F. The endocrine function of adipose tissue. Growth Genetics Horm 2002; 18:17-23.
247. Flier JS. Leptin expression and action: new experimental paradigms. Proc Natl Acad Sci U S A 1997; 94:4242-4245.
248. Flier JS. Clinical review 94: what’s in a name? In search of leptin’s physiologic role. J Clin Endocrinol Metab 1998; 83:1407-1413.
249. Campfiled LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269:546-549.
250. Krude H, Biebermann H, Schnabel D, et al. Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J Clin Endocrinol Metab 2003; 88:4633-4640.
251. Mergen M, Mergen H, Ozata M, Oner R, Oner C. A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity. J Clin Endocrinol Metab 2001; 86:3448.
252. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O’Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003; 348:1085-1095.
253. Branson R, Potoczna N, Kral JG, Lentes KU, Hoehe MR, Horber FF. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003; 348:1096-1103.
254. Kleinman RE, ed. Pediatric Obesity in Pediatric Nutrition Handbook. American Academy of Pediatrics, 2004:565.
255. Leibel RL, Chua SC, Rosenbaum M. Obesity: the molecular physiology of weight regulation. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 8th ed. New York: McGraw-Hill, 2001:3965-4028.
256. Chu NF, Wang DJ, Shieh SM, Rimm EB. Plasma leptin concentrations and obesity in relation to insulin resistance syndrome components among school children in Taiwan- The Taipei Children Heart Study. Int J Obes Relat Metab Disord 2000; 24:1265-1271.
257. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387:903-908.
258. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998; 18:213-215.
259. Mergen M, Mergen H, Ozata M, Oner R, Oner C. A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity. J Clin Endocrinol Metab 2001; 86:3448.
260. Heymsfield SB, Greenberg AS, Fujioka K, et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial JAMA 1999; 282:1568-1575.
261. Gibson WT, Farooqi IS, Moreau M, et al. Congenital leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy. J Clin Endocrinol Metab 2004; 89:4821-4826.
262. Korner J, Leibel RL. To eat or not to eat? How the gut talks to the brain. N Engl J Med 2003; 349:926-928.
263. Seeley RJ, Woods SC. Monitoring of stored and available fuel by the CNS: implications for obesity. Nat Rev Neurosci 2003; 4:901-909.
264. Schwartz MW, Porte D Jr. Diabetes, obesity, and the brain. Science 2005; 307:375-379.
265. Obici S, Feng Z, Arduini A, Conti R, Rossetti L. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med 2003; 9:756-761.
266. Obici S, Zhang BB, Karkanis G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 2002; 8:1376-1382.
267. List JF, Habener JF. Defective melanocortin 4 receptor in hyperphagia and morbid obesity. N Engl J Med 2003; 348: 1160-1163.
268. Gotoda T. Binge eating as a phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003; 349:606-609.
269. Bouret SG, Draper SJ, Simerly RB. Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 2004; 304:108-110.
270. Pinto S, Roseberry AG, Liu H, et al. Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 2004; 304:110-115.
271. Broglio F, Arvat E, Benso A, et al. Ghrelin: endocrine and non-endocrine actions. J Pediatr Endocrinol Metab 2002; 15:1219-1227.
272. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402:656-660.
273. Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature 2001; 409: 194-198.
274. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000; 407:908-913.
275. Soriano-Guillen L, Barrios V, Chowen JA, et al. Ghrelin levels from fetal life through early adulthood: relationship with endocrine and metabolic and anthropometric measures. J Pediatr 2004; 144:30-35.
276. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50:707-709.
277. Renshaw D, Batterham RL. Peptide YY: a potential therapy for obesity. Curr Drug Targets 2005; 6:171-179.
278. Di Marzo V, Goparaju SK, Wang L, et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001; 410:822-825.
279. Bensaid M, Gary-Bobo M, Escalngo A, et al. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol 2003; 63:908-914.
280. Howlett AC, Breivogal CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 2004; 47(suppl 1):345-358.
281. Di Marzo V, Bifulco M, De Petrocellis. The endocannabinoid system and its therapeutic applications. Nat Rev Drug Discov 2004; 3:771-784.
282. Ravinet Trillou C, Arnon M, Delgorge C, et al. Antiobesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol 2003; 284:345-353.
283. Cabeza de Vaca S, Hao J, Afroz T, Krahne LL, Carr KD. Feeding, body weight, and sensitivity to non-ingestive reward stimuli during and after 12-day continuous central infusions of melanocortin receptor ligands. Peptides 2005; 26:2314-2321.
284. Ramos EJ, Meguid MM, Campos AC, Coelho JC. Neuropeptide Y, alpha-melanocyte-stimulating hormone, and monoamines in food intake regulation. Nutrition 2005; 21:269-279.
285. Brunetti L, Di Nisio C, Orlando G, Ferrante C, Vacca M. The regulation of feeding: a cross talk between peripheral and central signalling. Int J Immunopathol Pharmacol 2005; 18:201-212.
286. Takahashi A, Ishimru H, Ikarashi Y, Maruyama Y. Aspects of hypothalamic neuronal systems in VMH lesioninduced obese rats. J Auton Nerv Syst 1994; 48:213-219.
287. Beglinger C. Overview. Cholecystokinin and eating. Curr Opin Investig Drugs 2002; 3:587-588.
288. Nauck MA, Meier JJ, Creutzfeldt W. Incretins and their analogues as new antidiabetic drugs. Drug News Perspect 2003; 16:413-422.
289. Tomasik PJ, Sztefko K, Starzyk J. Cholecystokinin, glucose dependent insulinotropic peptide and glucagon-like peptide 1 secretion in children with anorexia nervosa and simple obesity. J Pediatr Endocrinol Metab 2004; 17: 1623-1631.
290. Fan W, Ellacott KL, Halatchev IG, Takahashi K, Yu P, Cone RD. Cholecystokinin-mediated suppression of feeding involves the brainstem melanocortin system. Nat Neurosci 2004; 7:335-336.
291. Hirschberg AL, Naessen S, Stridsberg M, Bystrom B, Holtet J. Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome. Gynecol Endocrinol 2004; 19:79-87.
292. Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr 1987; 45:277S-282S.
293. Bjorntorp P. The regulation of adipose tissue distribution in humans. Int J Obes Rel Metab Disord 1996; 20:291-302.
294. Sethi J, Hotamisligil GS. The role of TNFa in adipocyte metabolism. Semin Cell Dev Biol 1999; 10:19-29.
295. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95:2409-2415.
296. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cystokines originating from adipose tissue? Arteriorcler Thromb Vasc Biol 1999; 19:972-978.
297. Shimomura I, Funahashi T, Takahashi M, et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 1996; 2:800-803.
298. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86:1930-1935.
299. Ogawa Y, Kikuchi T, Nagasaki K, et al. Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children. Hypertens Res 2005; 28:51-57.
300. Steppam CM, Lazar AM. Resistin and obesity-associated insulin resistance. Trends EndocrinolMetab 2002; 13:18-23.
301. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnet AH, Kumar S. Resistin, central obesity, and type 2 diabetes. Lancet 2002; 359:46-47.
302. Bo S, Gambino R, Pagani A, Guidi S, Gentile L, Cassader M, Pagano GF. Relationships between human serum resistin, inflammatory markers and insulin resistance. Int J Obes Relat Metab Disord 2005; xx:xx-xx.
303. Reinehr T, Roth CL, Menke T, Andler W. Resistin concentrations before and after weight loss in obese children. Int J Obes (Lond) 2005; 90:6386-6391.
304. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307:426-430.
305. Bray G, Gallagher TF Jr. Manifestations of hypothalamic obesity in man: a comprehensive investigation of eight patients and a review of the literature. Medicine (Baltimore) 1975; 54:301-330.
306. Didi M, Didock E, Davies HA, Oligvy-Stuart AL, Wales JKH, Shalet SM. High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia of childhood. J Pediatr 1995; 127:63-67.
307. Ullrich NJ, Scott RM, Pomeroy SL. Craniopharyngioma therapy. Long-term effects on hypothalamic function. Neurologist 2005; 11:55-60.
308. Thomsett MJ, Conte FA, Kaplan SL, et al. Endocrine and neurologic outcome in childhood craniopharyngioma: review of effect of treatment in 42 patients. J Pediatr 1980; 97:728-735.
309. Sorva R. Children with craniopharyngioma: early growth failure and rapid postoperative weight gain. Acta Paediatr Scand 1988; 77:587-592.
310. Sklar CA. Craniopharyngioma: endocrine sequalae of treatment. Pediatr Neurosurg 1994; 21:120-123.
311. Jeanrenaud B. A hypothesis on the aetiology of obesity: dysfunction of the central nervous system as a primary cause. Diabetologia 1985; 28:502-513.
312. Powley TL, Laughton W. Neural pathways involved in the hypothalamic integration of autonomic responses. Diabetologia 1981; 20:378-387.
313. Ionescu E, Rohner-Jeanrenaud F, Berthoud HR, Jeanrenaud B. Increases in plasma insulin levels in response to electrical stimulation of the dorsal motor nucleus of the vagus nerve. Endocrinology 1983; 112:904-910.
314. Rohner-Jeanrenaud F, Jeanrenaud B. Involvement of the cholinergic system in insulin and glucagon oversecretion of genetic preobesity. Endocrinology 1985; 116:830-834.
315. Lustig RH, Rose SR, Burghen GA, et al. Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by somatostatin agonist. J Pediatr 1999; 135:162-168.
316. Koontz AJ, MacDonald LM, Schade DS. Octreotide: a longactinginhibitorofendogenoushormone secretionforhuman metabolic investigations. Metabolism 1994; 43:24-31.
317. Ratcliffe SG, Bancroft J, Axworthy D, McLaren W. Klinefelter’s syndrome in adolescence. Arch Dis Child 1982; 57:6-12.
318. Polychronakos C, Letarte J, Collu R, Ducharme JR. Carbohydrate intolerance in children and adolescents with Turner syndrome. J Pediatr 1980; 96:1009-1014.
319. Jabbar M, Pugliese M, Fort P, Recker B, Lifshitz F. Excess weight and precocious pubarche in children: altera-somatostation-like immunoreactivity in obese children. Eur J Pediatr 1987; 146:48-50.
320. Kaplowitz PB, Slora EJ, Wasserman RC, Podlow SE, Herman-Giddens ME. Earlier onset of puberty in girls: relation to increased body mass index and race. Pediatrics 2001; 108:347-353.
321. Freedman DS, Srinivasan SR, Burke GL, et al. Relation of body fat distribution to hyperinsulinemia in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr 1987; 46:403-410.
322. Vanderschueren-Lodeweyckx M. The effect of single obesity on growth and growth hormone. Horm Res 1993; 40:23-30.
323. Bowers CY. A new dimension on the induced release of growth hormone in obese subjects. J Clin Endocrinol Metab 1993; 76:817-818.
324. Cordido F, Penalua A, Dieguez C, Casanueva FF. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. J Clin Endocrinol Metab 1993; 76:819-823.
325. Leroith D. Insulin-like growth factors. N Engl J Med 1997; 336:633-637.
326. Attia N, Tamborlane WV, Heptulla R, et al. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. J Clin Endocrinol Metab 1998; 83: 1467-1471.
327. Ballerini MG, Ropelato MG, Domene HM, Pennisi P, Heinrich JJ, Jasper HG. Differential impact of simple childhood obesity on the components of the growth hormone-insulin-like growth factor (IGF)-IGF binding proteins axis. J Pediatr Endocrinol Metab 2004; 17: 749-757.
328. Phillip M, Moran O, Lazar L. Growth without growth hormone. J Pediatr Endocrinol Metab 2002; 15(suppl 5): 1267-1272.
329. Gleeson HK, Lissett CA, Shalet SM. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity. J Clin Endocrinol Metab 2005; 90: 1061-1067.
330. Maor G, Rochwerger M, Segev Y, Phillip M. Leptin acts as a growth factor on the chondrocytes of skeletal growth centers. J Bone Miner Res 2002; 17:1034-1043.
331. Gat-Yablonski G, Ben-Ari T, Shtaif B, et al. Leptin reverses the inhibitory effect of caloric restriction on longitudinal growth. Endocrinology 2004; 145:343-350.
332. Forbes GB. Influence of nutrition. In: Forbes GB, ed. Human Body Composition: Growth, Aging, Nutrition and Activity. New York: Springer-Verlag, 1987:209-247.
333. Amador M, Ramos LT, Morono M, Hermelo MP. Growth rate reduction during energy restriction in obese adolescents. Exp Clin Endocrinol 1990; 96:73-82.
334. Epstein LH, Valoski A, McCurley J. Effect of weight loss by obese children on long-term growth. Am J Dis Child 1993; 147:1076-1080.
335. AvRuskin TW, Pillai S, Kasi K, Juan C, Kleinberg DL. Decreased prolactin secretion in childhood obesity. J Pediatr 1985; 106:373-378.
336. Lala VR, Ray A, Jamias P, et al. Prolactin and thyroid status in prepubertal children with mild to moderate obesity. J Am Coll Nutr 1988; 7:361-366.
337. Kopelman PG, Pilkington TR, Jeffcoate SL, White N. Persistence of defective hypothalamic control of prolactin secretion in some obese women after weight reduction. Br Med J 1980; 281:358-359.
338. Danforth E Jr. Adaptive thermogenesis and thyroid hormones. In: Bjorntorp P, Cairella M, Howard A, eds. Recent Advances in Obesity Research III. London: John Libbey, 1980:228-235.
339. Mancini A, Fiumara C, Conte G, et al. Pyridostigmine effects on TSH response to TRH in adult and children obese subjects. Horm Metab Res 1993; 25:309-311.
340. Kyle LH, Ball MF, Doolan PD. Effect of thyroid hormone on body composition in myxedema and obesity. N Engl J Med 1966; 275:12-17.
341. Clement K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392:398-401.
342. Bajari TM, Nimpf J, Schneider WJ. Role of leptin in reproduction. Curr Opin Lipidol 2004; 15:315-319.
343. Chiumello G, Brambilla P, Guarneri MP, Russo G, Manzoni P, Sgaramella P. Precocious puberty and body composition: effects of GnRH analog treatment. J Pediatr Endocrinol Metab 2000; 13:S791-S794.
344. Palmert MR, Mansfield MJ, Crowley WF Jr. Crigler JF Jr., Crawford JD, Boepple PA. Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty. J Clin Endocrinol Metab 1999; 12:4480-4488.
345. Kamycheva E, Sundsfjord J, Jorde R. Serum parathyroid hormone level is associated with body mass index. The 5th Tromso study. Eur J Endocrinol 2004; 151(2):167-172.
346. McCarty MF, Thomas CA. PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses 2003; 61:535-542.
347. Bolland MJ, Grey AB, Gamble GD, Reid IR. Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrinol Metab 2005; 90:1525-1530.
348. Shi H, Dirienzo D, Zemel MB. Effects of dietary calcium on adipocyte lipid metabolism and body weight regulation in energy-restricted aP2-agouti transgenic mice. FASEB J 2001; 15:291-293.
349. Zemel MB. Regulation of adiposity and obesity risk by dietary calcium: mechanisms and implications. J Am Coll Nutr 2002; 21(2):146S-151S.
350. Shi H, Norma AW, Okamura WH, Sen A, Zemal MB. 1alpha, 25-dihydroxyvitamin D3 inhibits uncoupling protein 2 expression in human adipocytes. FASEB J 2002; 16(13):1808-1810.
351. Zemel MB, Richards J, Mathis S, Milstead A, Gebhardt L, Silva E. Dairy augmentation of total and central fat loss in obese subjects. Int J Obes Relat Metab Disord 2005; 29: 391-397.
352. Zemela MB, Miller SL. Dietary calcium and dairy modulation of adiposity and obesity risk. Nutr Rev 2004; 62:125-131.
353. Pereira MA, Jacobs DR Jr., Van Horn L, Slattery ML, Kartashov AI, Ludwig DS. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA study. JAMA 2002; 287:2081-2089.
354. Niklas TA. Calcium intake trends and health consequences from childhood through adulthood. J Am Coll Nutr 2003; 22:340-356.
355. Veuglers PJ, Fitzgerald AL, Johnston E. Dietary intake and risk factors for poor diet quality among children in Nova Scotia. Can J Public Health 2005; 96:212-216.
356. Niklas TA, Demory-Luce D, Yang SJ, Baranowski T, Zakeri I, Berenson G. Children’s food consumption patterns have changed over two decades (1973-1994): the Bogalusa heart study. J Am Diet Assoc 2004; 104: 1127-1140.
357. Kozusko FP. Body weight setpoint, metabolic adaption and human starvation. Bull Math Biol 2001; 63:393-403.
358. Peters A, Schweiger U, Pellerin L, et al. The selfish brain: competition for energy resources. Neurosci Biobehav Rev 2004; 28:143-180.
359. Maxfield E, Konishi F. Patterns of food intake and physical activity in obesity. J Am Diet Assoc 1966; 49:406-408.
360. Dwyer JT, Feldman JJ, Mayer JK. Adolescent dieters: who are they? Physical characteristics, attitudes and dieting practices of adolescent girls. Am J Clin Nutr 1967; 20:1045-1056.
361. Rossner S. Weight cycling a 'ʼnew’' risk factor? J Intern Med 1989; 226:209-211.
362. Steen SN, Oppliger RA, Brownell KD. Metabolic effects of repeated weight loss and regain in adolescent wrestlers. JAMA 1988; 260:47-50.
363. Ravussin E, Lillioja S, Knowler WC, et al. Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 1988; 318:467-472.
364. Rising R, Fontvieille AM, Larson DE. Racial difference in body core temperature between Pima Indian and Caucasian men. Int J Obes Rel Metab Disord 1995; 19:1-5.
365. Rising R, Tataranni PA, Snitker S, Ravussin E. Decreased ratio of fat to carbohydrate oxidation with increasing age in Pima Indians. J Am Coll Nutr 1996; 15:309-312.
366. Bandini LG, Schoeller DA, Dietz WH. Energy expenditure in obese and nonobese adolescents. Pediatr Res 1990; 27:198-203.
367. Lichtman SW, Pisarska K, Berman ER, et al. Discrepancy between self-reported and actual caloric intake and exercise in obese subjects. N Engl J Med 1992; 327:1893-1898.
368. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 1995; 332:621-628.
369. Ravussin E. Physiology. A NEAT way to control weight? Science 2005; 307:530-531.
370. Levine JA, Lanningham-Foster LA, McCrady SK, et al. Interindividual variation in posture allocation: possible role in human obesity. Science 2005; 307:584-586.
371. Ravussin E, Lillioja S, Anderson TE, Christin L, Bogardus C. Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber. J Clin Invest 1986; 78:1568-1578.
372. Griffiths M, Payne PR. Energy expenditure in small children of obese and nonobese parents. Nature 1976; 260:698-700.
373. Zurlo F, Lillioja S, Puente AED, et al. Low ratio of fat to carbohydrate oxidation as a predictor of weight gain: study of 24-h RQ. Am J Physiol 1990; 259:E650-E657.
374. Rising R, Keys A, Ravussin E, Bogardus C. Concomitant interindividual variation in the body temperature and metabolic rate. Am J Physiol 1992; 263:E730-E734.
375. Spraul M, Ravussin E, Fontvieille AM, Rising R, Larson DE, Anderson EA. Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J Clin Invest 1993; 92:1730-1735.
376. Salbe AD, Weyer C, Harper I, Lindsay RS, Ravussin E, Tataranni PA. Assessing risk factors for obesity between childhood and adolescence: II. Energy metabolism and physical activity. Pediatrics 2002; 110:307-314.
377. Rowland TW. Exercise and Children’s Health. Champaign, IL: Human Kinetics Books, 1990:356.
378. Goran MI, Gower BA, Nagy TR, Johnson RK. Developmental changes in energy expenditure and physical activity in children: evidence for a decline in physical activity in girls before puberty. Pediatrics 1998; 101:887-891.
379. Garcia AW, Broda MA, Frenn M, Coviak C, Pender NJ, Ronis DL. Gender and developmental differences in exercise beliefs among youth and prediction of their exercise behavior. J School Health 1995; 65:213-219.
380. Strauss RS, Rodzilsky D, Burack G, Colin M. Psychosocial correlates of physical activity in healthy children. Arch Pediatr Adolesc Med 2001; 155:897-902.
381. Bullen BA, Reed RB, Mayer J. Physical activity of obese and nonobese adolescent girls appraised by motion picture sampling. Am J Clin Nutr 1964; 14:211-223.
382. Waxman M, Stunkard AJ. Caloric intake and expenditure of obese boys. J Pediatr 1980; 96:187-193.
383. Maffeis C, Schutz Y, Schena F, Zaffanello M, Pinelli L. Energy expenditure during walking and running in obese and nonobese prepubertal children. J Pediatr 1993; 123: 193-199.
384. Gorn GJ, Goldberg ME. Behavioral evidence for the effects of televised food messages on children. J Consumer Res 1982; 9:200-205.
385. Klesges RC, Shelton ML, Klesges LM. Effects of television on metabolic rate: potential implications for childhood obesity. Pediatrics 1993; 91:281-286.
386. Jeffrey DB, McLellarn RW, Fox DT. The development of children’s eating habits: the role of television commercials. Health Educ Q 1982; 9:174-189.
387. Williams TM, Handford AG. Television and other leisure activities. In: Williams TM, ed. The Impact of Television: A Natural Experiment in Three Communities. Orlando, FL: Academic Press, 1986:143-213.
388. Dietz WH Jr., Gortmaker SL. Do we fatten our children at the television set? Obesity and television viewing in children and adolescents. Pediatrics 1985; 75:807-812.
389. Andersen RE, Crespo CJ, Bartlett SJ, Cheskin LJ, Pratt M. Relationship of physical activity and television watching with body weight and level of fatness among children: results from the Third National Health and Nutrition Examination Survey. JAMA 1998; 279:938-942.
390. Dennison BA, Erb TA, Jenkins PL. Television viewing and television in bedroom associated with overweight risk among low-income preschool children. Pediatrics 2002; 109:1028-1035.
391. Prentice AM, Lucas A, Vasquez-Velaquez L, Davies PS, Whitehead RG. Are current dietary guidelines for young children a prescription for overfeeding? Lancet 1988; 2:1066-1069.
392. Energy and protein requirements. Report of a joint FAO/WHO ad hoc expert committee, Rome, March 22 to April 2, 1971. FAO Nutr Meet Rep Ser 1973; 52:1-118.
393. Goran MI, Carpenter WH, Poehlman ET. Total energy expenditure in 4-to-6-yr-old children. Am J Physiol 1993; 264:E706-E711.
394. Fontvieille AM, Harper IT, Ferraro RT, Spraul M, Ravussin E. Daily energy expenditure by five-year-old children measured by doubly labeled water. J Pediatr 1993; 123:200-207.
395. Wei M, Kampert JB, Barlow CE, et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA 1999; 282:1547-1553.
396. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002; 346:793-801.
397. Katzmarzyck PT, Church TS, Janssen I, Ross R, Blair SN. Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness. Diabetes Care 2005; 28: 391-397.
398. Lee S, Kuk JL, Katzmarzyck PT, Blair SN, Church TS, Ross R. Cardiorespiratory fitness attenuates metabolic risk independent of abdominal subcutaneous and visceral fat in men. Diabetes Care 2005; 28:895-901.
399. Schoeller DA. How accurate is self-reported dietary energy intake? Nutr Rev 1990; 48:373-379.
400. Mertz W, Tsui JC, Judd JT, et al. What are people really eating? The relation between energy intake derived from estimated diet records and intake determined to maintain body weight. Am J Clin Nutr 1991; 54:291-295.
401. Bandini LG, Schoeller DA, Cyr HN, Dietz WH. Validity of reported energy intake in obese and nonobese adolescents. Am J Clin Nutr 1990; 52:421-425.
402. Sclafani A, Springer D. Dietary obesity in adult rats: similarities in hypothalamic and human obesity syndromes. Physiol Behav 1976; 17:461-471.
403. Fisher JQ, Rolls BJ, Birch LL. Children’s bite size and intake of an entrée are greater with large portions than with age appropriate or self selected portions. Am J Clin Nutr 2003; 77:1170-1184.
404. Rolls BJ, Engell D, Birch LL. Serving portion size influences 5 year old but not 3 year old children’s food intake. J Am Diet Assoc 2000; 100:232-234.
405. Flatt JP, Ravussin E, Acheson KJ, Jequier E. Effects of dietary fat on postprandial substrate oxidation and on carbohydrate and fat balances. J Clin Invest 1985; 76: 1019-1024.
406. Schutz Y, Flatt JP, Jequier E. Failure of dietary fat intake to promote fat oxidation: a factor favoring the development of obesity. Am J Clin Nutr 1989; 50:307-314.
407. Golay A, Bobbioni E. The role of dietary fat in obesity. Int J Obes Rel Metab Disord 1997; 21:S2-S11.
408. Rolls BJ, Shide DJ. The influence of dietary fat on food intake and body weight. Nutr Rev 1992; 50:283-290.
409. America Heart Association. Dietary guidelines for healthy American adults: a statement for health professionals from the nutrition committee. Circulation 1996; 94:1795-1800.
410. American Diabetes Association. Nutrition recommendations and principles for people with diabetes mellitus. Diabetes Care 2000; 23:S43-S46.
411. Katan MB, Grundy SM, Willett WC. Should a low-fat, high-carbohydrate diet be recommended for everyone? Beyond low-fat diets. N Engl J Med 1997; 337:563-566.
412. Larson DE, Hunter GR, Williams MJ, Kekes-Szabo T, Nyikos I, Goran MI. Dietary fat in relation to body fat and intraabdominal adipose tissue: a cross-sectional analysis. Am J Clin Nutr 1996; 64:787-788.
413. Allred JB. Too much of a good thing? An overemphasis on eating low-fat foods may be contributing to the alarming increase in overweight among US adults. J Am Diet Assoc 1995; 95:417-418.
414. Nicklas TA. Dietary studies of children: the Bogalusa Heart Study experience. J Am Diet Assoc 1995; 95: 1127-1133.
415. Kant AK, Graubard BI, Schatzkin A, Ballard-Barbash R. Proportions of energy intake from fat and subsequent weight change in the NHANES 1 epidemiologic followup study. Am J Clin Nutr 1995; 61:11-17.
416. Lissner L, Heitman BL. Dietary fat and obesity: evidence from epidemiology. Eur J Clin Nutr 1995; 49:79-90.
417. Lenfant C, Ernst N. Daily dietary fat and total energy hyperinsulinemia of obesity. N Engl J Med 1971; 285: 827-831.
418. Stephen AM, Wald NJ. Trends in individual consumption of dietary fat in the United States, 1920-1984. Am J Clin Nutr 1990; 52:457-469.
419. Wolever TM, Jenkins DJ, Jenkins AL, Josse RG. The glycemic index: methodology and clinical implications. Am J Clin Nutr 1991; 54:846-854.
420. Bjork I, Granfeldt Y, Liljeberg H, Tovar J, Asp N-G. Food properties affecting the digestion and absorption of carbohydrates. Am J Clin Nutr 1994; 59:699S-705S.
421. Granfeldt Y, Hagander B, Bjork I. Metabolic responses to starch in oat and wheat products. On the importance of food structure, incomplete gelatinization or presence of viscous dietary fiber. Eur J Clin Nutr 1995; 49:189-199.
422. Welch IM, Bruce C, Hill SE, Read NW. Duodenal and ileal lipid suppresses postprandial blood glucose and insulin responses in man: possible implications for dietary management of diabetes mellitus. Clin Sci 1987; 72:209-216.
423. Trout DL, Behall KM, Osilesi O. Prediction of glycemic index for starchy foods. Am J Clin Nutr 1993; 58:873-878.
424. Foster-Powell K, Miller JB. International tables of glycemic index. Am J Clin Nutr 1995; 62:871S-890S.
425. Stephen AM, Sieber GM, Gerster YA, Morgan DR. Intake of carbohydrate and its component-international comparisons, trends overtime, and effects of changing to low fat diet. Am J Clin Nutr 1995; 62:851S-867S.
426. Nicklas TA, Webber LS, Koschak ML, Berenson GS. Nutrient adequacy of low fat intakes for children: the Bogalusa Heart Study. Pediatrics 1992; 89:221-228.
427. Popkin BM, Haines PS, Patterson RE. Dietary changes in older Americans 1977-1987. Am J Clin Nutr 1992; 55: 823-830.
428. Harnack LJ, Jeffery RW, Boutelle KN. Temporal trends in energy intake in the United States: an ecologic perspective. Am J Clin Nutr 2000; 71:1478-1484.
429. Lifshitz F. Commentary: Soft drinks replacing healthier alternatives in American diet. AAP News 2002; 20:36-37.
430. Grey NJ, Goldring S, Kipnis DM. The effect of fasting, diet, and actinomycin D on insulin secretion in the rat. J Clin Invest 1970; 49:881-889.
431. Grey NJ, Kipnis DM. Effect of diet composition on the hyperinsulinemia of obesity. N Engl J Med 1971; 285: 827-831.
432. Dennison BA, Rockwell HL, Baker SL. Excess fruit juice consumption by preschool-aged children is associated with short stature and obesity. Pediatrics 1997; 99:15-22.
433. Bagdade JD, Bierman EL, Porte D Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest 1967; 46:1549-1557.
434. Floyd JC Jr., Fajans SS, Conn JW, Khoph RF, Rull J. Stimulation of insulin secretion by amino acids. J Clin Invest 1966; 1487-1502.
435. Rabinowitz D, Zierler KL. Forearm metabolism in obesity and its response to intra-arterial insulin. Characterization of insulin resistance and evidence for adaptive hyperinsulinism. J Clin Invest 1962; 41:2173-2181.
436. Ludwig DS, Majzoub JA, Al-Zahrani A, Dallal GE, Blanco I, Roberts SB. High glycemic index foods, overeating, and obesity. Pediatrics 1999; 103:E26.
437. Spieth LE, Harnish JD, Lenders CM, et al. A low-glycemic index diet in the treatment of pediatric obesity. Arch Pediatr Adolesc Med 2000; 154:947-951.
438. Bray GA. Lipogenesis in human adipose tissue: some effects of nibbling and gorging. J Clin Invest 1972; 51: 537-548.
439. Fabry P, Tepperman J. Meal frequency a possible factor in human pathology. Am J Clin Nutr 1970; 23:1059-1068.
440. Dietschy JM, Brown MS. Effect of alterations of the specific activity of the intracellular acetyl CoA pool on apparent rates of hepatic cholesterogenesis. J Lipid Res 1974; 15:508-516.
441. Lakshmanan MR, Nepokroeff CM, Ness GC, Dugan RE, Porter JW. Stimulation by insulin of rat liver b-hydroxyb-methylglutaryl coenzyme A reductase and cholesterolsynthesizing activities. Biochem Biophys Res Commun 1973; 50:704-710.
442. Jenkins DJ, Wolever TM, Vuksan V, et al. Nibbling verses gorging: metabolic advantages of increased meal frequency. N Engl J Med 1989; 321:929-934.
443. Acheson K, Jequier E, Wahren J. Influence of β-adrenergic blockade on glucose-induced thermogenesis in man. J Clin Invest 1983; 72:981-986.